Adaptive Frontier Exploration on Graphs with Applications to Network-Based Disease Testing

TL;DR

This paper introduces an adaptive frontier exploration method on graphs for maximizing rewards under practical constraints, with applications in network-based disease testing, demonstrating superior performance over baselines.

Contribution

It develops a Gittins index-based policy for frontier exploration on graphs, providing provable optimality for forests and efficient implementation for general graphs.

Findings

Outperforms baseline methods in synthetic and real-world experiments.

Achieves near-complete detection of positive cases in HIV testing simulations.

Efficiently balances exploration and exploitation under practical constraints.

Abstract

We study a sequential decision-making problem on a $n$-node graph $\mathcal{G}$ where each node has an unknown label from a finite set $\mathbf{\Omega}$, drawn from a joint distribution $\mathcal{P}$ that is Markov with respect to $\mathcal{G}$. At each step, selecting a node reveals its label and yields a label-dependent reward. The goal is to adaptively choose nodes to maximize expected accumulated discounted rewards. We impose a frontier exploration constraint, where actions are limited to neighbors of previously selected nodes, reflecting practical constraints in settings such as contact tracing and robotic exploration. We design a Gittins index-based policy that applies to general graphs and is provably optimal when $\mathcal{G}$ is a forest. Our implementation runs in $\mathcal{O}(n^2 \cdot |\mathbf{\Omega}|^2)$ time while using $\mathcal{O}(n \cdot |\mathbf{\Omega}|^2)$ oracle calls to $\mathcal{P}$ and $\mathcal{O}(n^2 \cdot |\mathbf{\Omega}|)$ space. Experiments on synthetic and real-world graphs show that our method consistently outperforms natural baselines, including in non-tree, budget-limited, and undiscounted settings. For example, in HIV testing simulations on real-world sexual interaction networks, our policy detects nearly all positive cases with only half the population tested, substantially outperforming other baselines.